"ICx is a leader in numerous technologies relating to homeland security and force protection, including chemical, biological, nuclear, radiological and explosive (CBRNE) detection, as well as advanced sensor systems for perimeter security," said Colin Cumming, CEO of ICx Technologies. "This technological diversity demands deep expertise across many disciplines including advanced materials, molecular biology, bioengineering, photonics, mass spectrometry and nanotechnology. Wayne is uniquely qualified to provide innovation and strong leadership to our scientists and engineers engaged in research & development in these fields."
Prior to joining ICx, Dr. Bryden was a program manager for the Defense Advanced Research Projects Agency (DARPA). Dr. Bryden ran several high-profile programs that focused on revolutionizing the response to battlefield attacks by chemical and biological agents. He also previously worked on program development and management of emerging technological ventures at the Johns Hopkins University Applied Physics Lab.
About ICx Technologies(TM)
ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Our proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. We then leverage our unparalleled technical expertise and government funding to address other emerging challenges of our time, ranging from a cleaner environment and alternative energy to life science.
Statements contained in this press release that are not historical facts are "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements, including statements relating to ICx Technologies' plans, objectives and expectations for future operations, are uncertain and subject to a variety of risks that could cause actual results to differ materially from those expected by ICx Technologies. You should consider the risk factors described in ICx Technologies' prospectus as filed with the U.S. Securities and Exchange Commission on November 8, 2007, as well as other filings.
ICx Technologies undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE: ICx Technologies
ICx Technologies Media Contact Vicki Contavespi, + 1-571-209-7660 vicki.contavespi@icxt.com or Investor Relations Jessica Bartlow, + 1-703-678-2114 jessica.bartlow@icxt.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index